Table Of Contents :
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 16
2.1 What is This Report About? 16
3 Cardiovascular Devices In Belgium 17
3.1 Cardiovascular Devices, Market Segmentation 17
3.2 Cardiovascular Devices, Belgium, Overall Revenue ($m), 2002-2016 18
3.3 Cardiovascular Devices Market, Belgium, Revenue Mix ($m), 2009 19
3.4 Cardiovascular Devices Market, Belgium, Category Contribution (%), 2009 20
3.5 Cardiovascular Devices, Belgium, Category Volume (Units), 2002-2016 26
3.6 Cardiovascular Devices, Belgium, Company Share (2008-2009) 31
4 Cardiac Rhythm Management In Belgium 33
4.1 Cardiac Rhythm Management, Market Segmentation 33
4.2 Cardiac Rhythm Management Market, Belgium, Revenue Mix ($m), 2009 34
4.3 Cardiac Rhythm Management Market, Belgium, Category Contribution (%), 2009 35
4.4 Cardiac Rhythm Management Overall Revenue (2002-2016) 36
4.4.1 Cardiac Resynchronisation Therapy Revenue (2002-2016) 38
4.4.2 Implantable Cardioverter Defibrillator Revenue (2002-2016) 40
4.4.3 Pacemaker Revenue (2002-2016) 42
4.4.4 External Defibrillator Revenue (2002-2016) 44
4.5 Cardiac Rhythm Management Overall Volume (2002-2016) 46
4.5.1 Cardiac Resynchronisation Therapy Volume (2002-2016) 48
4.5.2 Implantable Cardioverter Defibrillator Revenue (2002-2016) 50
4.5.3 Pacemaker Volume (2002-2016) 52
4.5.4 External Defibrillator Volume (2002-2016) 54
4.6 Cardiac Rhythm Management Average Price (2002-2016) 56
4.7 Cardiac Rhythm Management Distribution Share (2008-2009) 58
4.8 Cardiac Rhythm Management, Belgium, Company Share (2008-2009) 59
5 Cardiovascular Monitoring and Diagnostic Devices In Belgium 61
5.1 Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 61
5.2 Cardiovascular Monitoring and Diagnostic Devices Market, Belgium, Revenue Mix ($m), 2009 62
5.3 Cardiovascular Monitoring and Diagnostic Devices Market, Belgium, Category Contribution (%), 2009 63
5.4 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2002-2016) 64
5.5 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2002-2016) 67
5.6 Cardiovascular Monitoring and Diagnostic Devices Average Price (2002-2016) 69
5.7 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2008-2009) 70
5.8 Cardiovascular Monitoring and Diagnostic Devices, Belgium, Company Share (2008-2009) 71
6 Cardiovascular Prosthetic Devices In Belgium 73
6.1 Cardiovascular Prosthetic Devices, Market Segmentation 73
6.2 Cardiovascular Prosthetic Devices Market, Belgium, Revenue Mix ($m), 2009 74
6.3 Cardiovascular Prosthetic Devices Market, Belgium, Category Contribution (%), 2009 75
6.4 Cardiovascular Prosthetic Devices Overall Revenue (2002-2016) 76
6.4.1 Cardiac Assist Devices Revenue (2002-2016) 78
6.4.2 Prosthetic Heart Valve Revenue (2002-2016) 80
6.5 Cardiovascular Prosthetic Devices Overall Volume (2002-2016) 82
6.5.1 Cardiac Assist Devices Volume (2002-2016) 84
6.5.2 Prosthetic Heart Valve Volume (2002-2016) 86
6.6 Cardiovascular Prosthetic Devices Average Price (2002-2016) 88
6.7 Cardiovascular Prosthetic Devices Distribution Share (2008-2009) 89
6.8 Cardiovascular Prosthetic Devices, Belgium, Company Share (2008-2009) 90
7 Cardiovascular Surgery In Belgium 92
7.1 Cardiovascular Surgery, Market Segmentation 92
7.2 Cardiovascular Surgery Market, Belgium, Revenue Mix ($m), 2009 93
7.3 Cardiovascular Surgery Market, Belgium, Category Contribution (%), 2009 94
7.4 Cardiovascular Surgery Overall Revenue (2002-2016) 95
7.4.1 Perfusion Disposables Revenue (2002-2016) 99
7.5 Cardiovascular Surgery Overall Volume (2002-2016) 101
7.5.1 Perfusion Disposables Volume (2002-2016) 103
7.6 Cardiovascular Surgery Average Price (2002-2016) 105
7.7 Cardiovascular Surgery Distribution Share (2008-2009) 106
7.8 Cardiovascular Surgery, Belgium, Company Share (2008-2009) 107
8 Electrophysiology In Belgium 108
8.1 Electrophysiology, Market Segmentation 108
8.2 Electrophysiology Market, Belgium, Revenue Mix ($m), 2009 109
8.3 Electrophysiology Market, Belgium, Category Contribution (%), 2009 110
8.4 Electrophysiology Overall Revenue (2002-2016) 111
8.5 Electrophysiology Overall Volume (2002-2016) 113
8.6 Electrophysiology Average Price (2002-2016) 115
8.7 Electrophysiology Distribution Share (2008-2009) 116
8.8 Electrophysiology, Belgium, Company Share (2008-2009) 117
9 Interventional Cardiology In Belgium 119
9.1 Interventional Cardiology, Market Segmentation 119
9.2 Interventional Cardiology Market, Belgium, Revenue Mix ($m), 2009 120
9.3 Interventional Cardiology Market, Belgium, Category Contribution (%), 2009 121
9.4 Interventional Cardiology Overall Revenue (2002-2016) 122
9.4.1 Cardiac Catheter Revenue (2002-2016) 126
9.4.2 Coronary Stent Revenue (2002-2016) 128
9.4.3 PTCA Balloon Revenue (2002-2016) 130
9.5 Interventional Cardiology Overall Volume (2002-2016) 132
9.5.1 Cardiac Catheter Volume (2002-2016) 134
9.5.2 Coronary Stent Volume (2002-2016) 136
9.5.3 PTCA Balloon Volume (2002-2016) 138
9.6 Interventional Cardiology Average Price (2002-2016) 140
9.7 Interventional Cardiology Distribution Share (2008-2009) 142
9.8 Interventional Cardiology, Belgium, Company Share (2008-2009) 143
10 Peripheral Vascular Devices In Belgium 145
10.1 Peripheral Vascular Devices, Market Segmentation 145
10.2 Peripheral Vascular Devices Market, Belgium, Revenue Mix ($m), 2009 146
10.3 Peripheral Vascular Devices Market, Belgium, Category Contribution (%), 2009 147
10.4 Peripheral Vascular Devices Overall Revenue (2002-2016) 148
10.5 Peripheral Vascular Devices Overall Volume (2002-2016) 152
10.6 Peripheral Vascular Devices Average Price (2002-2016) 156
10.7 Peripheral Vascular Devices Distribution Share (2008-2009) 157
10.8 Peripheral Vascular Devices, Belgium, Company Share (2008-2009) 158
11 Overview of Key Companies in Belgium Cardiovascular Devices Market 160
11.1 Medtronic, Inc. 160
11.1.1 Company Overview 160
11.1.2 Share in the Belgium Cardiovascular Devices Market 160
11.2 Boston Scientific Corporation 161
11.2.1 Company Overview 161
11.2.2 Share in the Belgium Cardiovascular Devices Market 161
11.3 St. Jude Medical, Inc. 162
11.3.1 Company Overview 162
11.3.2 Share in the Belgium Cardiovascular Devices Market 162
11.4 BIOTRONIK SE & Co. KG 163
11.4.1 Company Overview 163
11.4.2 Share in the Belgium Cardiovascular Devices Market 163
11.5 Cordis Corporation 164
11.5.1 Company Overview 164
11.5.2 Share in the Belgium Cardiovascular Devices Market 164
11.6 Abbott Laboratories 165
11.6.1 Company Overview 165
11.6.2 Share in the Belgium Cardiovascular Devices Market 165
11.7 Sorin S.p.A. 166
11.7.1 Company Overview 166
11.7.2 Share in the Belgium Cardiovascular Devices Market 166
11.8 AtriCure, Inc. 167
11.8.1 Company Overview 167
11.9 Biosense Webster, Inc. 167
11.9.1 Company Overview 167
11.10 C. R. Bard, Inc. 168
11.10.1 Company Overview 168
11.11 Thoratec Corporation 168
11.11.1 Company Overview 168
11.12 GE Healthcare 169
11.12.1 Company Overview 169
11.13 Philips Healthcare 169
11.13.1 Company Overview 169
11.14 Edwards Lifesciences Corporation 169
11.14.1 Company Overview 169
11.15 Terumo Corporation 170
11.15.1 Company Overview 170
11.16 Welch Allyn Inc. 170
11.16.1 Company Overview 170
11.17 Nihon Kohden Corporation 171
11.17.1 Company Overview 171
11.18 OSI Systems, Inc. 171
11.18.1 Company Overview 171
11.19 ABIOMED, Inc. 172
11.19.1 Company Overview 172
11.20 Cardiac Science Corporation 172
11.20.1 Company Overview 172
11.21 MAQUET GmbH & Co. KG 173
11.21.1 Company Overview 173
11.22 Cook Medical Incorporated 173
11.22.1 Company Overview 173
11.23 W. L. Gore & Associates, Inc. 173
11.23.1 Company Overview 173
11.24 ev3 Inc. 174
11.24.1 Company Overview 174
12 Cardiovascular Devices Market Pipeline Products 175
13 Financial Deals Landscape 190
13.1 Partnerships 190
13.1.1 Argon Medical Devices Enters Into Licensing Agreement With Rex Medical 190
13.1.2 Cardiac Network Signs Licensing Agreement With Pacific Innovations 191
13.1.3 BIOTRONIK Enters Into Exclusive Distribution Agreement With Endosense 192
14 Recent Developments 193
14.1 Government and Public Interest 193
14.1.1 Mar 18, 2010: Bailout Stenting Helps Treat Constricted Aortas In Just Born 193
14.2 Product News 193
14.2.1 Mar 22, 2010: ATS Medical Gains Canadian Approval For Commercialization Of Simulus Annuloplasty Product Line 193
14.2.2 Feb 23, 2010: OLV Hospital To Complete First Phase Of Certification Training To Implant SynCardia Temporary CardioWest Total Artificial Heart 194
14.2.3 Feb 04, 2010: St. Jude Medical Gets CE Mark Approval For Fortify ST ICD And Unify CRT-D Defibrillators 194
15 Appendix 196
15.1 Definitions of Markets Covered in the Report 197
15.1.1 Cardiovascular Devices 197
15.2 Research Methodology 204
15.3 Secondary Research 205
15.4 Primary Research 205
15.5 Models 206
15.6 Forecasts 206
15.7 Expert Panels 206
15.8 GlobalData Consulting 206
15.9 Currency Conversion 207
15.10 Contact Us 207
15.11 Disclaimer 207
1.1 List of Tables
Table 1: Cardiovascular Devices, Belgium, Overall Revenue ($m), 2002-2016 18
Table 2: Cardiovascular Devices Market, Belgium, Category Contribution (%), 2009 20
Table 3: Cardiovascular Devices Market, Belgium, Cross-Category Analysis,2002-2016 21
Table 4: Cardiovascular Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009 23
Table 5: Cardiovascular Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016 25
Table 6: Cardiovascular Devices, Belgium, Category Volume (Units), 2002-2016 26
Table 7: Cardiovascular Devices, Belgium, Category Volume (Units), Historic, 2002-2009 28
Table 8: Cardiovascular Devices, Belgium, Category Volume (Units), Forecast, 2009-2016 30
Table 9: Cardiovascular Devices, Belgium, Company Share by Revenue ($m), 2008-2009 32
Table 10: Cardiac Rhythm Management Market, Belgium, Category Contribution (%), 2009 35
Table 11: Cardiac Rhythm Management, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 36
Table 12: Cardiac Rhythm Management, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 37
Table 13: Cardiac Resynchronisation Therapy, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Table 14: Cardiac Resynchronisation Therapy, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 39
Table 15: Implantable Cardioverter Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Table 16: Implantable Cardioverter Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Table 17: Pacemaker, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 42
Table 18: Pacemaker, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 43
Table 19: External Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 44
Table 20: External Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 45
Table 21: Cardiac Rhythm Management, Belgium, Volume (Units) by Segment, Historic, 2002-2009 46
Table 22: Cardiac Rhythm Management, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 47
Table 23: Cardiac Resynchronisation Therapy, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 48
Table 24: Cardiac Resynchronisation Therapy, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 49
Table 25: Implantable Cardioverter Defibrillator, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 50
Table 26: Implantable Cardioverter Defibrillator, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 51
Table 27: Pacemaker, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 52
Table 28: Pacemaker, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 53
Table 29: External Defibrillator, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 54
Table 30: External Defibrillator, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 55
Table 31: Cardiac Rhythm Management, Belgium, Average Price ($), Historic, 2002-2009 56
Table 32: Cardiac Rhythm Management, Belgium, Average Price ($), Forecast, 2009-2016 57
Table 33: Cardiac Rhythm Management, Belgium, Distribution Share by Revenue ($m), 2008-2009 58
Table 34: Cardiac Rhythm Management, Belgium, Company Share by Revenue ($m), 2008-2009 60
Table 35: Cardiovascular Monitoring and Diagnostic Devices Market, Belgium, Category Contribution (%), 2009 63
Table 36: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 65
Table 37: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 66
Table 38: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 67
Table 39: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 68
Table 40: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Average Price ($), Historic, 2002-2009 69
Table 41: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Average Price ($), Forecast, 2009-2016 69
Table 42: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Distribution Share by Revenue ($m), 2008-2009 70
Table 43: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Company Share by Revenue ($m), 2008-2009 72
Table 44: Cardiovascular Prosthetic Devices Market, Belgium, Category Contribution (%), 2009 75
Table 45: Cardiovascular Prosthetic Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 76
Table 46: Cardiovascular Prosthetic Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 77
Table 47: Cardiac Assist Devices, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78
Table 48: Cardiac Assist Devices, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 79
Table 49: Prosthetic Heart Valve, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 80
Table 50: Prosthetic Heart Valve, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81
Table 51: Cardiovascular Prosthetic Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 82
Table 52: Cardiovascular Prosthetic Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 83
Table 53: Cardiac Assist Devices, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 84
Table 54: Cardiac Assist Devices, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 85
Table 55: Prosthetic Heart Valve, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 86
Table 56: Prosthetic Heart Valve, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 87
Table 57: Cardiovascular Prosthetic Devices, Belgium, Average Price ($), Historic, 2002-2009 88
Table 58: Cardiovascular Prosthetic Devices, Belgium, Average Price ($), Forecast, 2009-2016 88
Table 59: Cardiovascular Prosthetic Devices, Belgium, Distribution Share by Revenue ($m), 2008-2009 89
Table 60: Cardiovascular Prosthetic Devices, Belgium, Company Share by Revenue ($m), 2008-2009 91
Table 61: Cardiovascular Surgery Market, Belgium, Category Contribution (%), 2009 94
Table 62: Cardiovascular Surgery, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 96
Table 63: Cardiovascular Surgery, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 98
Table 64: Perfusion Disposables, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 99
Table 65: Perfusion Disposables, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 100
Table 66: Cardiovascular Surgery, Belgium, Volume (Units) by Segment, Historic, 2002-2009 101
Table 67: Cardiovascular Surgery, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 102
Table 68: Perfusion Disposables, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 103
Table 69: Perfusion Disposables, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 104
Table 70: Cardiovascular Surgery, Belgium, Average Price ($), Historic, 2002-2009 105
Table 71: Cardiovascular Surgery, Belgium, Average Price ($), Forecast, 2009-2016 105
Table 72: Cardiovascular Surgery, Belgium, Distribution Share by Revenue ($m), 2008-2009 106
Table 73: Cardiovascular Surgery, Belgium, Company Share by Revenue ($m), 2008-2009 107
Table 74: Electrophysiology Market, Belgium, Category Contribution (%), 2009 110
Table 75: Electrophysiology, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 111
Table 76: Electrophysiology, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 112
Table 77: Electrophysiology, Belgium, Volume (Units) by Segment, Historic, 2002-2009 113
Table 78: Electrophysiology, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 114
Table 79: Electrophysiology, Belgium, Average Price ($), Historic, 2002-2009 115
Table 80: Electrophysiology, Belgium, Average Price ($), Forecast, 2009-2016 115
Table 81: Electrophysiology, Belgium, Distribution Share by Revenue ($m), 2008-2009 116
Table 82: Electrophysiology, Belgium, Company Share by Revenue ($m), 2008-2009 118
Table 83: Interventional Cardiology Market, Belgium, Category Contribution (%), 2009 121
Table 84: Interventional Cardiology, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 123
Table 85: Interventional Cardiology, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 125
Table 86: Cardiac Catheter, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 126
Table 87: Cardiac Catheter, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 127
Table 88: Coronary Stent, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 128
Table 89: Coronary Stent, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 129
Table 90: PTCA Balloon, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 130
Table 91: PTCA Balloon, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 131
Table 92: Interventional Cardiology, Belgium, Volume (Units) by Segment, Historic, 2002-2009 132
Table 93: Interventional Cardiology, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 133
Table 94: Cardiac Catheter, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 134
Table 95: Cardiac Catheter, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 135
Table 96: Coronary Stent, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 136
Table 97: Coronary Stent, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 137
Table 98: PTCA Balloon, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 138
Table 99: PTCA Balloon, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 139
Table 100: Interventional Cardiology, Belgium, Average Price ($), Historic, 2002-2009 140
Table 101: Interventional Cardiology, Belgium, Average Price ($), Forecast, 2009-2016 141
Table 102: Interventional Cardiology, Belgium, Distribution Share by Revenue ($m), 2008-2009 142
Table 103: Interventional Cardiology, Belgium, Company Share by Revenue ($m), 2008-2009 144
Table 104: Peripheral Vascular Devices Market, Belgium, Category Contribution (%), 2009 147
Table 105: Peripheral Vascular Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 149
Table 106: Peripheral Vascular Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 151
Table 107: Peripheral Vascular Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 153
Table 108: Peripheral Vascular Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 155
Table 109: Peripheral Vascular Devices, Belgium, Average Price ($), Historic, 2002-2009 156
Table 110: Peripheral Vascular Devices, Belgium, Average Price ($), Forecast, 2009-2016 156
Table 111: Peripheral Vascular Devices, Belgium, Distribution Share by Revenue ($m), 2008-2009 157
Table 112: Peripheral Vascular Devices, Belgium, Company Share by Revenue ($m), 2008-2009 159
Table 113: Cardiovascular Devices Market Pipeline Products 175
Table 114: Argon Medical Devices Enters Into Licensing Agreement With Rex Medical 190
Table 115: Cardiac Network Signs Licensing Agreement With Pacific Innovations 191
Table 116: BIOTRONIK Enters Into Exclusive Distribution Agreement With Endosense 192
Table 117: USD to Local Currency, Belgium, Average Actual Rate 2002-2009 207
1.2 List of Figures
Figure 1: Cardiovascular Devices, Market Segmentation 17
Figure 2: Cardiovascular Devices, Belgium, Overall Revenue ($m), 2002-2016 18
Figure 3: Cardiovascular Devices Market, Belgium, Revenue Mix ($m), 2009 19
Figure 4: Cardiovascular Devices Market, Belgium, Category Contribution (%), 2009 20
Figure 5: Cardiovascular Devices Market, Belgium, Cross-Category Analysis,2002-2016 21
Figure 6: Cardiovascular Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009 22
Figure 7: Cardiovascular Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016 24
Figure 8: Cardiovascular Devices, Belgium, Category Volume (Units), 2002-2016 26
Figure 9: Cardiovascular Devices, Belgium, Category Volume (Units), Historic, 2002-2009 27
Figure 10: Cardiovascular Devices, Belgium, Category Volume (Units), Forecast, 2009-2016 29
Figure 11: Cardiovascular Devices, Belgium, Company Share (%), 2009 31
Figure 12: Cardiac Rhythm Management, Market Segmentation 33
Figure 13: Cardiac Rhythm Management Market, Belgium, Revenue Mix ($m), 2009 34
Figure 14: Cardiac Rhythm Management Market, Belgium, Category Contribution (%), 2009 35
Figure 15: Cardiac Rhythm Management, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 36
Figure 16: Cardiac Rhythm Management, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 37
Figure 17: Cardiac Resynchronisation Therapy, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 38
Figure 18: Cardiac Resynchronisation Therapy, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 39
Figure 19: Implantable Cardioverter Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40
Figure 20: Implantable Cardioverter Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41
Figure 21: Pacemaker, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 42
Figure 22: Pacemaker, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 43
Figure 23: External Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 44
Figure 24: External Defibrillator, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 45
Figure 25: Cardiac Rhythm Management, Belgium, Volume (Units) by Segment, Historic, 2002-2009 46
Figure 26: Cardiac Rhythm Management, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 47
Figure 27: Cardiac Resynchronisation Therapy, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 48
Figure 28: Cardiac Resynchronisation Therapy, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 49
Figure 29: Implantable Cardioverter Defibrillator, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 50
Figure 30: Implantable Cardioverter Defibrillator, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 51
Figure 31: Pacemaker, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 52
Figure 32: Pacemaker, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 53
Figure 33: External Defibrillator, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 54
Figure 34: External Defibrillator, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 55
Figure 35: Cardiac Rhythm Management, Belgium, Company Share (%), 2009 59
Figure 36: Cardiovascular Monitoring and Diagnostic Devices, Market Segmentation 61
Figure 37: Cardiovascular Monitoring and Diagnostic Devices Market, Belgium, Revenue Mix ($m), 2009 62
Figure 38: Cardiovascular Monitoring and Diagnostic Devices Market, Belgium, Category Contribution (%), 2009 63
Figure 39: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 64
Figure 40: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 66
Figure 41: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 67
Figure 42: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 68
Figure 43: Cardiovascular Monitoring and Diagnostic Devices, Belgium, Company Share (%), 2009 71
Figure 44: Cardiovascular Prosthetic Devices, Market Segmentation 73
Figure 45: Cardiovascular Prosthetic Devices Market, Belgium, Revenue Mix ($m), 2009 74
Figure 46: Cardiovascular Prosthetic Devices Market, Belgium, Category Contribution (%), 2009 75
Figure 47: Cardiovascular Prosthetic Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 76
Figure 48: Cardiovascular Prosthetic Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 77
Figure 49: Cardiac Assist Devices, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78
Figure 50: Cardiac Assist Devices, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 79
Figure 51: Prosthetic Heart Valve, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 80
Figure 52: Prosthetic Heart Valve, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81
Figure 53: Cardiovascular Prosthetic Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 82
Figure 54: Cardiovascular Prosthetic Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 83
Figure 55: Cardiac Assist Devices, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 84
Figure 56: Cardiac Assist Devices, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 85
Figure 57: Prosthetic Heart Valve, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 86
Figure 58: Prosthetic Heart Valve, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 87
Figure 59: Cardiovascular Prosthetic Devices, Belgium, Company Share (%), 2009 90
Figure 60: Cardiovascular Surgery, Market Segmentation 92
Figure 61: Cardiovascular Surgery Market, Belgium, Revenue Mix ($m), 2009 93
Figure 62: Cardiovascular Surgery Market, Belgium, Category Contribution (%), 2009 94
Figure 63: Cardiovascular Surgery, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 95
Figure 64: Cardiovascular Surgery, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 97
Figure 65: Perfusion Disposables, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 99
Figure 66: Perfusion Disposables, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 100
Figure 67: Cardiovascular Surgery, Belgium, Volume (Units) by Segment, Historic, 2002-2009 101
Figure 68: Cardiovascular Surgery, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 102
Figure 69: Perfusion Disposables, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 103
Figure 70: Perfusion Disposables, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 104
Figure 71: Cardiovascular Surgery, Belgium, Company Share (%), 2009 107
Figure 72: Electrophysiology, Market Segmentation 108
Figure 73: Electrophysiology Market, Belgium, Revenue Mix ($m), 2009 109
Figure 74: Electrophysiology Market, Belgium, Category Contribution (%), 2009 110
Figure 75: Electrophysiology, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 111
Figure 76: Electrophysiology, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 112
Figure 77: Electrophysiology, Belgium, Volume (Units) by Segment, Historic, 2002-2009 113
Figure 78: Electrophysiology, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 114
Figure 79: Electrophysiology, Belgium, Company Share (%), 2009 117
Figure 80: Interventional Cardiology, Market Segmentation 119
Figure 81: Interventional Cardiology Market, Belgium, Revenue Mix ($m), 2009 120
Figure 82: Interventional Cardiology Market, Belgium, Category Contribution (%), 2009 121
Figure 83: Interventional Cardiology, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 122
Figure 84: Interventional Cardiology, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 124
Figure 85: Cardiac Catheter, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 126
Figure 86: Cardiac Catheter, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 127
Figure 87: Coronary Stent, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 128
Figure 88: Coronary Stent, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 129
Figure 89: PTCA Balloon, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009 130
Figure 90: PTCA Balloon, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 131
Figure 91: Interventional Cardiology, Belgium, Volume (Units) by Segment, Historic, 2002-2009 132
Figure 92: Interventional Cardiology, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 133
Figure 93: Cardiac Catheter, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 134
Figure 94: Cardiac Catheter, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 135
Figure 95: Coronary Stent, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 136
Figure 96: Coronary Stent, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 137
Figure 97: PTCA Balloon, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009 138
Figure 98: PTCA Balloon, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016 139
Figure 99: Interventional Cardiology, Belgium, Company Share (%), 2009 143
Figure 100: Peripheral Vascular Devices, Market Segmentation 145
Figure 101: Peripheral Vascular Devices Market, Belgium, Revenue Mix ($m), 2009 146
Figure 102: Peripheral Vascular Devices Market, Belgium, Category Contribution (%), 2009 147
Figure 103: Peripheral Vascular Devices, Belgium, Revenue ($m) by Segment, Historic, 2002-2009 148
Figure 104: Peripheral Vascular Devices, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016 150
Figure 105: Peripheral Vascular Devices, Belgium, Volume (Units) by Segment, Historic, 2002-2009 152
Figure 106: Peripheral Vascular Devices, Belgium, Volume (Units) by Segment, Forecast, 2009-2016 154
Figure 107: Peripheral Vascular Devices, Belgium, Company Share (%), 2009 158
Figure 108: Medtronic, Inc., Company Share (%), Belgium Cardiovascular Devices Market, 2009 160
Figure 109: Boston Scientific Corporation, Company Share (%),Belgium Cardiovascular Devices Market, 2009 161
Figure 110: St. Jude Medical, Inc., Company Share (%),Belgium Cardiovascular Devices Market, 2009 162
Figure 111: BIOTRONIK SE & Co. KG, Company Share (%),Belgium Cardiovascular Devices Market, 2009 163
Figure 112: Cordis Corporation, Company Share (%),Belgium Cardiovascular Devices Market, 2009 164
Figure 113: Abbott Laboratories, Company Share (%),Belgium Cardiovascular Devices Market, 2009 165
Figure 114: Abbott Laboratories, Company Share (%),Belgium Cardiovascular Devices Market, 2009 166
Figure 115: GlobalData Methodology 204
|
